Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch®): a systematic review.

Deltour I, Poulsen AH, Johansen C et al (2022) Time trends in mobile phone use and glioma incidence among males in the Nordic Countries, 1979–2016. Environ Int 168:107487

pubmed: 36041243 pmcid: 9463632 doi: 10.1016/j.envint.2022.107487

Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492–507

pubmed: 18669428 doi: 10.1056/NEJMra0708126

Stupp R, Brada M, van den Bent MJ et al (2014) High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 25:iii93–iii101

pubmed: 24782454 doi: 10.1093/annonc/mdu050

Crocetti E, Trama A, Stiller C et al (2012) Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer 48:1532–1542

pubmed: 22227039 doi: 10.1016/j.ejca.2011.12.013

Ostrom QT, Gittleman H, Xu J et al (2016) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009–2013. Neuro Oncol 18:v1–v75

pubmed: 28475809 pmcid: 8483569 doi: 10.1093/neuonc/now207

Kawauchi D, Ohno M, Honda-Kitahara M, et al (2022) The clinical characteristics and outcomes of incidentally discovered glioblastoma. J Neurooncol

Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251

pubmed: 34185076 pmcid: 8328013 doi: 10.1093/neuonc/noab106

Ius T, Pignotti F, Della Pepa GM et al (2020) A novel comprehensive clinical stratification model to refine prognosis of glioblastoma patients undergoing surgical resection. Cancers (Basel) 12:386

pubmed: 32046132 doi: 10.3390/cancers12020386

Lemee JM, Clavreul A, Menei P (2015) Intratumoral heterogeneity in glioblastoma: don’t forget the peritumoral brain zone. Neuro Oncol 17:1322–1332

pubmed: 26203067 pmcid: 4578587 doi: 10.1093/neuonc/nov119

Ohgaki H (2009) Epidemiology of brain tumors. In: Verma M (ed) Cancer epidemiology. Humana Press, Totowa, NJ, pp 323–342

doi: 10.1007/978-1-60327-492-0_14

Weller M, van den Bent M, Preusser M et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18:170–186

pubmed: 33293629 doi: 10.1038/s41571-020-00447-z

Brito C, Azevedo A, Esteves S et al (2019) Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. BMC Cancer 19:968

pubmed: 31623593 pmcid: 6798410 doi: 10.1186/s12885-019-6177-0

Chen D, Persson A, Sun Y et al (2013) Better prognosis of patients with glioma expressing FGF2-dependent PDGFRA irrespective of morphological diagnosis. PLoS ONE 8:e61556

pubmed: 23630597 pmcid: 3632602 doi: 10.1371/journal.pone.0061556

AIOM (2017) Linee guida Neoplasie Cerebrali 2017, p. 1–54

Oz G, Alger JR, Barker PB et al (2014) Clinical proton MR spectroscopy in central nervous system disorders. Radiology 270:658–679

pubmed: 24568703 doi: 10.1148/radiol.13130531

Kim JY, Park JE, Jo Y et al (2019) Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients. Neuro Oncol 21:404–414

pubmed: 30107606 doi: 10.1093/neuonc/noy133

Chuang DF, Lin X (2019) Targeted therapies for the treatment of glioblastoma in adults. Curr Oncol Rep 21:61

pubmed: 31102038 doi: 10.1007/s11912-019-0807-1

Brandes AA, Tosoni A, Franceschi E et al (2008) Glioblastoma in adults. Crit Rev Oncol Hematol 67:139–152

pubmed: 18394916 doi: 10.1016/j.critrevonc.2008.02.005

Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466

pubmed: 19269895 doi: 10.1016/S1470-2045(09)70025-7

Zigiotto L, Annicchiarico L, Corsini F et al (2020) Effects of supra-total resection in neurocognitive and oncological outcome of high-grade gliomas comparing asleep and awake surgery. J Neurooncol 148:97–108

pubmed: 32303975 doi: 10.1007/s11060-020-03494-9

Sarubbo S, Annicchiarico L, Corsini F et al (2021) planning brain tumor resection using a probabilistic atlas of cortical and subcortical structures critical for functional processing: a proof of concept. Operative Neurosurg 20:E175–E183

doi: 10.1093/ons/opaa396

Katsevman GA, Turner RC, Urhie O et al (2019) Utility of sodium fluorescein for achieving resection targets in glioblastoma: increased gross- or near-total resections and prolonged survival. J Neurosurg 132:914–920

pubmed: 30738388 doi: 10.3171/2018.10.JNS181174

Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198

pubmed: 11780887 doi: 10.3171/jns.2001.95.2.0190

Delgado-Lopez PD, Corrales-Garcia EM (2016) Survival in glioblastoma: a review on the impact of treatment modalities. Clin Transl Oncol 18:1062–1071

pubmed: 26960561 doi: 10.1007/s12094-016-1497-x

Sirven JI, Wingerchuk DM, Drazkowski JF et al (2004) Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 79:1489–1494

pubmed: 15595331 doi: 10.4065/79.12.1489

Tremont-Lukats IW, Ratilal BO, Armstrong T et al (2008) Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database System Rev 2010:CD004424

Garbossa D, Panciani PP, Angeleri R et al (2013) A retrospective two-center study of antiepileptic prophylaxis in patients with surgically treated high-grade gliomas. Neurol India 61:131–137

pubmed: 23644311 doi: 10.4103/0028-3886.111118

You G, Sha Z, Jiang T (2020) Clinical diagnosis and perioperative management of glioma-related epilepsy. Front Oncol 10:550353

pubmed: 33520690 doi: 10.3389/fonc.2020.550353

Walbert T, Harrison RA, Schiff D et al (2021) SNO and EANO practice guideline update: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neuro Oncol 23:1835–1844

pubmed: 34174071 pmcid: 8563323 doi: 10.1093/neuonc/noab152

Galicich JH, French LA, Melby JC (1961) Use of dexamethasone in treatment of cerebral edema associated with brain tumors. J Lancet 81:46–53

pubmed: 13703072

Kostaras X, Cusano F, Kline GA et al (2014) Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline. Curr Oncol 21:e493-503

pubmed: 24940109 pmcid: 4059813 doi: 10.3747/co.21.1769

Wong ET, Swanson KD (2019) Dexamethasone-friend or foe for patients with glioblastoma? JAMA Neurol 76:247–248

pubmed: 30667471 doi: 10.1001/jamaneurol.2018.4530

Farge D, Frere C, Connors JM et al (2019) 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol 20:e566–e581

pubmed: 31492632 doi: 10.1016/S1470-2045(19)30336-5

Ellingson BM, Bendszus M, Boxerman J et al (2015) Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials. Neuro Oncol 17:1188–1198

pubmed: 26250565 pmcid: 4588759

Bernstock JD, Gary SE, Klinger N et al (2022) Standard clinical approaches and emerging modalities for glioblastoma imaging. Neurooncol Adv 4:vdac080

pubmed: 35821676 pmcid: 9268747

Lundy P, Domino J, Ryken T et al (2020) The role of imaging for the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update. J Neurooncol 150:95–120

pubmed: 33215340 doi: 10.1007/s11060-020-03597-3

Karschnia P, Vogelbaum MA, van den Bent M et al (2021) Evidence-based recommendations on categories for extent of resection in diffuse glioma. Eur J Cancer 149:23–33

pubmed: 33819718 doi: 10.1016/j.ejca.2021.03.002

Riva M, Lopci E, Gay LG et al (2021) Advancing imaging to enhance surgery: from image to information guidance. Neurosurg Clin N Am 32:31–46

pubmed: 33223024 doi: 10.1016/j.nec.2020.08.003

Albert NL, Weller M, Suchorska B et al (2016) Response assessment in neuro-oncology working group and European Association for neuro-oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol 18:1199–1208

pubmed: 27106405 pmcid: 4999003 doi: 10.1093/neuonc/now058

Lu VM, Goyal A, Graffeo CS et al (2019) Survival benefit of maximal resection for glioblastoma reoperation in the temozolomide era: a meta-analysis. World Neurosurg 127:31–37

pubmed: 30947000 doi: 10.1016/j.wneu.2019.03.250

Li XZ, Li YB, Cao Y et al (2017) Prognostic implications of resection extent for patients with glioblastoma multiforme: a meta-analysis. J Neurosurg Sci 61:631–639

pubmed: 26824196 doi: 10.23736/S0390-5616.16.03619-5

Jackson C, Choi J, Khalafallah AM et al (2020) A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma. J Neurooncol 148:419–431

pubmed: 32562247 doi: 10.1007/s11060-020-03556-y

Brown TJ, Brennan MC, Li M et al (2016) Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol 2:1460

pubmed: 27310651 pmcid: 6438173 doi: 10.1001/jamaoncol.2016.1373

Berger MS, Ojemann GA (1992) Intraoperative brain mapping techniques in neuro-oncology. Stereotact Funct Neurosurg 58:153–161

pubmed: 1439333 doi: 10.1159/000098989

De Witt Hamer PC, Robles SG, Zwinderman AH et al (2012) Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. J Clin Oncol 30:2559–2565

pubmed: 22529254 doi: 10.1200/JCO.2011.38.4818

Bello L, Gambini A, Castellano A et al (2008) Motor and language DTI fiber tracking combined with intraoperative subcortical mapping for surgical removal of gliomas. Neuroimage 39:369–382

pubmed: 17911032 doi: 10.1016/j.neuroimage.2007.08.031

Gerritsen JKW, Arends L, Klimek M et al (2019) Impact of intraoperative stimulation mapping on high-grade glioma surgery outcome: a meta-analysis. Acta Neurochir 161:99–107

pubmed: 30465276 doi: 10.1007/s00701-018-3732-4

Gerritsen JKW, Vietor CL, Rizopoulos D et al (2019) Awake craniotomy versus craniotomy under general anesthesia without surgery adjuncts for supratentorial glioblastoma in eloquent areas: a retrospective matched case-control study. Acta Neurochir 161:307–315

pubmed: 30617715 doi: 10.1007/s00701-018-03788-y

Zhang JJY, Lee KS, Voisin MR et al (2020) Awake craniotomy for resection of supratentorial glioblastoma: a systematic review and meta-analysis. Neurooncol Adv 2:vdaa111

pubmed: 33063012 pmcid: 7542985

Pallud J, Dezamis E (2017) Functional and oncological outcomes following awake surgical resection using intraoperative cortico-subcortical functional mapping for supratentorial gliomas located in eloquent areas. Neurochirurgie 63:208–218

pubmed: 28161013 doi: 10.1016/j.neuchi.2016.08.003

Rasmussen IA Jr, Lindseth F, Rygh OM et al (2007) Functional neuronavigation combined with intra-operative 3D ultrasound: initial experiences during surgical resections close to eloquent brain areas and future directions in automatic brain shift compensation of preoperative data. Acta Neurochir 149:365–378

pubmed: 17308976 doi: 10.1007/s00701-006-1110-0

Wadley J, Dorward N, Kitchen N et al (1999) Pre-operative planning and intra-operative guidance in modern neurosurgery: a review of 300 cases. Ann R Coll Surg Engl 81:217–225

pubmed: 10615186 pmcid: 2503267

Feigl GC, Ritz R, Moraes M et al (2010) Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. J Neurosurg 113:352–357

pubmed: 19911888 doi: 10.3171/2009.10.JNS09447

Kuhn SA, Romeike B, Walter J et al (2009) Multiplanar MRI-CT fusion neuronavigation-guided serial stereotactic biopsy of human brain tumors: proof of a strong correlation between tumor imaging and histopathology by a new technical approach. J Cancer Res Clin Oncol 135:1293–1302

pubmed: 19308448 doi: 10.1007/s00432-009-0571-y

Willems PW, Taphoorn MJ, Burger H et al (2006) Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial. J Neurosurg 104:360–368

pubmed: 16572647 doi: 10.3171/jns.2006.104.3.360

Wirtz CR, Albert FK, Schwaderer M et al (2000) The benefit of neuronavigation for neurosurgery analyzed by its impact on glioblastoma surgery. Neurol Res 22:354–360

pubmed: 10874684 doi: 10.1080/01616412.2000.11740684

Barbagallo GMV, Palmucci S, Visocchi M et al (2016) Portable intraoperative computed tomography scan in image-guided surgery for brain high-grade gliomas: analysis of technical feasibility and impact on extent of tumor resection. Operative neurosurgery 12:19–30

pubmed: 29506245 doi: 10.1227/NEU.0000000000001112

Lekht I, Brauner N, Bakhsheshian J et al (2016) Versatile utilization of real-time intraoperative contrast-enhanced ultrasound in cranial neurosurgery: technical note and retrospective case series. Neurosurg Focus 40:E6

pubmed: 26926064 pmcid: 5101076 doi: 10.3171/2015.11.FOCUS15570

Coburger J, Scheuerle A, Kapapa T et al (2015) Sensitivity and specificity of linear array intraoperative ultrasound in glioblastoma surgery: a comparative study with high field intraoperative MRI and conventional sector array ultrasound. Neurosurg Rev 38:499–509

pubmed: 25855197 doi: 10.1007/s10143-015-0627-1

Eljamel MS, Mahboob SO (2016) The effectiveness and cost-effectiveness of intraoperative imaging in high-grade glioma resection; a comparative review of intraoperative ALA, fluorescein, ultrasound and MRI. Photodiagn Photodyn Ther 16:35–43

doi: 10.1016/j.pdpdt.2016.07.012

Finck T, Gempt J, Krieg SM et al (2020) Assessment of the extent of resection in surgery of high-grade glioma-evaluation of black blood sequences for intraoperative magnetic resonance imaging at 3 Tesla. Cancers (Basel) 12:1580

pubmed: 32549304 doi: 10.3390/cancers12061580

Li P, Qian R, Niu C et al (2017) Impact of intraoperative MRI-guided resection on resection and survival in patient with gliomas: a meta-analysis. Curr Med Res Opin 33:621–630

pubmed: 28008781 doi: 10.1080/03007995.2016.1275935

Kubben PL, ter Meulen KJ, Schijns OE et al (2011) Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review. Lancet Oncol 12:1062–1070

pubmed: 21868286 doi: 10.1016/S1470-2045(11)70130-9

Lo YT, Lee H, Shui C et al (2021) Intraoperative magnetic resonance imaging for low-grade and high-grade gliomas: what is the evidence? A meta-analysis. World Neurosurg 149:232–243

pubmed: 33540099 doi: 10.1016/j.wneu.2021.01.089

La Rocca G, Della Pepa GM, Menna G et al (2019) State of the art of fluorescence guided techniques in neurosurgery. J Neurosurg Sci 63:619–624

pubmed: 31961115

Pichlmeier U, Bink A, Schackert G et al (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10:1025–1034

pubmed: 18667747 pmcid: 2719000 doi: 10.1215/15228517-2008-052

Stummer W, Reulen HJ, Meinel T et al (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564–576

pubmed: 18425006 doi: 10.1227/01.neu.0000317304.31579.17

Diez Valle R, Tejada Solis S, Idoate Gastearena MA et al (2011) Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol 102:105–113

pubmed: 20607351 doi: 10.1007/s11060-010-0296-4

Gandhi S, Tayebi Meybodi A, Belykh E et al (2019) Survival outcomes among patients with high-grade glioma treated with 5-aminolevulinic acid-guided surgery: a systematic review and meta-analysis. Front Oncol 9:620

pubmed: 31380272 pmcid: 6652805 doi: 10.3389/fonc.2019.00620

Mazurek M, Kulesza B, Stoma F et al (2020) Characteristics of fluorescent intraoperative dyes helpful in gross total resection of high-grade gliomas—-a systematic review. Diagnostics 10:1100

pubmed: 33339439 pmcid: 7766001 doi: 10.3390/diagnostics10121100

Eatz TA, Eichberg DG, Lu VM et al (2022) Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review. J Neurooncol 156:233–256

pubmed: 34989964 doi: 10.1007/s11060-021-03901-9

Eljamel S (2015) 5-ALA fluorescence image guided resection of glioblastoma multiforme: a meta-analysis of the literature. Int J Mol Sci 16:10443–10456

pubmed: 25961952 pmcid: 4463655 doi: 10.3390/ijms160510443

Neira JA, Ung TH, Sims JS et al (2017) Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance. J Neurosurg 127:111–122

pubmed: 27715437 doi: 10.3171/2016.7.JNS16232

Acerbi F, Broggi M, Eoli M et al (2014) Is fluorescein-guided technique able to help in resection of high-grade gliomas? Neurosurg Focus 36:E5

pubmed: 24484258 doi: 10.3171/2013.11.FOCUS13487

Nikova AS, Vlotinou P, Karelis L et al (2022) Gross total resection with fluorescence could lead to improved overall survival rates: a systematic review and meta-analysis. Br J Neurosurg 36:316–322

pubmed: 34313526 doi: 10.1080/02688697.2021.1950637

Acerbi F, Cavallo C, Broggi M et al (2014) Fluorescein-guided surgery for malignant gliomas: a review. Neurosurg Rev 37:547–557

pubmed: 24756415 doi: 10.1007/s10143-014-0546-6

Ius T, Cesselli D, Isola M et al (2018) Combining clinical and molecular data to predict the benefits of carmustine wafers in newly diagnosed high-grade gliomas. Curr Treat Options Neurol 20:3

pubmed: 29476361 doi: 10.1007/s11940-018-0489-2

Ius T, Pignotti F, Della Pepa GM et al (2022) Glioblastoma: from volumetric analysis to molecular predictors. J Neurosurg Sci 66:173–186

pubmed: 32031360 doi: 10.23736/S0390-5616.20.04850-X

Pallud J, Audureau E, Noel G et al (2015) Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort. Neuro Oncol 17:1609–1619

pubmed: 26185110 pmcid: 4633930 doi: 10.1093/neuonc/nov126

Ricciardi L, Manini I, Cesselli D et al (2022) Carmustine wafers implantation in patients with newly diagnosed high grade glioma: is it still an option? Front Neurol 13:884158

pubmed: 35812101 pmcid: 9259966 doi: 10.3389/fneur.2022.884158

Wen PY, Weller M, Lee EQ et al (2020) Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol 22:1073–1113

pubmed: 32328653 pmcid: 7594557 doi: 10.1093/neuonc/noaa106

Bette S, Barz M, Wiestler B et al (2018) Prognostic value of tumor volume in glioblastoma patients: size also matters for patients with incomplete resection. Ann Surg Oncol 25:558–564

pubmed: 29159745 doi: 10.1245/s10434-017-6253-0

Wang L, Liang B, Li YI et al (2019) What is the advance of extent of resection in glioblastoma surgical treatment—-a systematic review. Chinese neurosurgical journal 5:2

pubmed: 32922902 pmcid: 7398311 doi: 10.1186/s41016-018-0150-7

Zeppa P, Neitzert L, Mammi M et al (2020) How reliable are volumetric techniques for high-grade gliomas? A comparison study of different available tools. Neurosurgery 87:E672–E679

pubmed: 32629469 doi: 10.1093/neuros/nyaa282

Eigenbrod S, Trabold R, Brucker D et al (2014) Molecular stereotactic biopsy technique improves diagnostic accuracy and enables personalized treatment strategies in glioma patients. Acta Neurochir 156:1427–1440

pubmed: 24792966 doi: 10.1007/s00701-014-2073-1

Hamisch CA, Minartz J, Blau T et al (2019) Frame-based stereotactic biopsy of deep-seated and midline structures in 511 procedures: feasibility, risk profile, and diagnostic yield. Acta Neurochir 161:2065–2071

pubmed: 31359191 doi: 10.1007/s00701-019-04020-1

Shooman D, Belli A, Grundy PL (2010) Image-guided frameless stereotactic biopsy without intraoperative neuropathological examination. J Neurosurg 113:170–178

pubmed: 20136389 doi: 10.3171/2009.12.JNS09573

Coburger J, Wirtz CR, Konig RW (2017) Impact of extent of resection and recurrent surgery on clinical outcome and overall survival in a consecutive series of 170 patients for glioblastoma in intraoperative high field magnetic resonance imaging. J Neurosurg Sci 61:233–244

pubmed: 26149222 doi: 10.23736/S0390-5616.16.03284-7

Delgado-Fernandez J, Garcia-Pallero MA, Blasco G et al (2017) Usefulness of reintervention in recurrent glioblastoma: an indispensable weapon for increasing survival. World Neurosurg 108:610–617

pubmed: 28939537 doi: 10.1016/j.wneu.2017.09.062

Perrini P, Gambacciani C, Weiss A et al (2017) Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis. J Neurooncol 131:585–591

pubmed: 27844310 doi: 10.1007/s11060-016-2330-7

Quick J, Gessler F, Dutzmann S et al (2014) Benefit of tumor resection for recurrent glioblastoma. J Neurooncol 117:365–372

pubmed: 24535317 doi: 10.1007/s11060-014-1397-2

Wann A, Tully PA, Barnes EH et al (2018) Outcomes after second surgery for recurrent glioblastoma: a retrospective case-control study. J Neurooncol 137:409–415

pubmed: 29294233 doi: 10.1007/s11060-017-2731-2

Botros D, Dux H, Price C et al (2021) Assessing the efficacy of repeat resections in recurrent glioblastoma: a systematic review. Neurosurg Rev 44:1259–1271

pubmed: 32533385 doi: 10.1007/s10143-020-01331-1

Lu VM, Jue TR, McDonald KL et al (2018) The survival effect of repeat surgery at glioblastoma recurrence and its trend: a systematic review and meta-analysis. World Neurosurg 115:453–459

pubmed: 29654958 doi: 10.1016/j.wneu.2018.04.016

McBain C, Lawrie TA, Rogozinska E et al (2021) Treatment options for progression or recurrence of glioblastoma: a network meta-analysis. Cochrane Database System Rev 5:CD013579

Ryken TC, Kalkanis SN, Buatti JM et al (2014) The role of cytoreductive surgery in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. J Neurooncol 118:479–488

pubmed: 24756348 doi: 10.1007/s11060-013-1336-7

Asmaa A, Dixit S, Rowland-Hill C et al (2018) Management of elderly patients with glioblastoma-multiforme-a systematic review. Br J Radiol 91:20170271

pubmed: 29376741 doi: 10.1259/bjr.20170271

Hanna C, Lawrie TA, Rogozinska E et al (2020) Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis. Cochrane Database System Rev 3:CD013261

Zarnett OJ, Sahgal A, Gosio J et al (2015) Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis. JAMA Neurol 72:589–596

pubmed: 25822375 doi: 10.1001/jamaneurol.2014.3739

McKinnon C, Nandhabalan M, Murray SA et al (2021) Glioblastoma: clinical presentation, diagnosis, and management. BMJ 374:n1560

pubmed: 34261630 doi: 10.1136/bmj.n1560

Chang SM, Parney IF, Huang W et al (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557–564

pubmed: 15687310 doi: 10.1001/jama.293.5.557

Perry JR, Julian JA, Laperriere NJ et al (2010) PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thrombosis Haemostasis 8:1959–1965

doi: 10.1111/j.1538-7836.2010.03973.x

Schmidt F, Faul C, Dichgans J et al (2002) Low molecular weight heparin for deep vein thrombosis in glioma patients. J Neurol 249:1409–1412

pubmed: 12382158 doi: 10.1007/s00415-002-0855-5

Agnelli G, Piovella F, Buoncristiani P et al (1998) Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 339:80–85

pubmed: 9654538 doi: 10.1056/NEJM199807093390204

Iorio A, Agnelli G (2000) Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med 160:2327–2332

pubmed: 10927730 doi: 10.1001/archinte.160.15.2327

Turpie AG, Gallus A, Beattie WS et al (1977) Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf. Neurology 27:435–438

pubmed: 558547 doi: 10.1212/WNL.27.5.435

Constantini S, Kanner A, Friedman A et al (2001) Safety of perioperative minidose heparin in patients undergoing brain tumor surgery: a prospective, randomized, double-blind study. J Neurosurg 94:918–921

pubmed: 11409520 doi: 10.3171/jns.2001.94.6.0918

Gerber DE, Segal JB, Salhotra A et al (2007) Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxis. Cancer 109:300–305

pubmed: 17154163 doi: 10.1002/cncr.22405

Alshehri N, Cote DJ, Hulou MM et al (2016) Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis. J Neurooncol 130:561–570

pubmed: 27591773 doi: 10.1007/s11060-016-2259-x

Zwicker JI, Karp Leaf R, Carrier M (2016) A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation. J Thromb Haemost 14:1736–1740

pubmed: 27306689 doi: 10.1111/jth.13387

Herting CJ, Chen Z, Maximov V et al (2019) Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema. Brain 142:3834–3851

pubmed: 31665239 pmcid: 6906596 doi: 10.1093/brain/awz331

Chang SM, Messersmith H, Ahluwalia M et al (2019) Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines. Neuro Oncol 21:424–427

pubmed: 30883663 pmcid: 6422436 doi: 10.1093/neuonc/noz034

Dekker M (1995) Use of glucocorticoids in neuro-oncology. In: Neurological complications of cancer. New Yotk, p. 199

Lim-Fat MJ, Bi WL, Lo J et al (2019) Letter: when less is more: dexamethasone dosing for brain tumors. Neurosurgery 85:E607–E608

pubmed: 31215634 pmcid: 6904720 doi: 10.1093/neuros/nyz186

Vecht CJ, Hovestadt A, Verbiest HB et al (1994) Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day. Neurology 44:675–680

pubmed: 8164824 doi: 10.1212/WNL.44.4.675

Ryken TC, McDermott M, Robinson PD et al (2010) The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:103–114

pubmed: 19957014 doi: 10.1007/s11060-009-0057-4

Kaal EC, Vecht CJ (2004) The management of brain edema in brain tumors. Curr Opin Oncol 16:593–600

pubmed: 15627023 doi: 10.1097/01.cco.0000142076.52721.b3

Henker C, Kriesen T, Glass Ä et al (2017) Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival. J Neurooncol 135:391–402

pubmed: 28755324 doi: 10.1007/s11060-017-2587-5

Pitter KL, Tamagno I, Alikhanyan K et al (2016) Corticosteroids compromise survival in glioblastoma. Brain 139:1458–1471

pubmed: 27020328 pmcid: 5006251 doi: 10.1093/brain/aww046

van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421–430

pubmed: 17434097 doi: 10.1016/S1474-4422(07)70103-5

Ruda R, Bello L, Duffau H et al (2012) Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro Oncol 14(Suppl 4):iv55-64

pubmed: 23095831 pmcid: 3480244 doi: 10.1093/neuonc/nos199

Rossi J, Cavallieri F, Biagini G et al (2022) Epileptogenesis and tumorigenesis in glioblastoma: which relationship? Medicina 58:1349

pubmed: 36295510 pmcid: 9606940 doi: 10.3390/medicina58101349

Radin DP, Tsirka SE (2020) Interactions between tumor cells, neurons, and microglia in the glioma microenvironment. Int J Mol Sci 21

Rossetti AO, Stupp R (2010) Epilepsy in brain tumor patients. Curr Opin Neurol 23:603–609

pubmed: 20733482 doi: 10.1097/WCO.0b013e32833e996c

Rosati A, Buttolo L, Stefini R et al (2010) Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study. Arch Neurol 67:343–346

pubmed: 20212232 doi: 10.1001/archneurol.2009.335

Usery JB, Michael LM 2nd, Sills AK et al (2010) A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures. J Neurooncol 99:251–260

pubmed: 20146087 doi: 10.1007/s11060-010-0126-8

Maschio M, Dinapoli L, Gomellini S et al (2010) Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy. J Neurooncol 98:109–116

pubmed: 19937087 doi: 10.1007/s11060-009-0069-0

Saria MG, Corle C, Hu J et al (2013) Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical article. J Neurosurg 118:1183–1187

pubmed: 23451905 doi: 10.3171/2013.1.JNS12397

Rossetti AO, Jeckelmann S, Novy J et al (2014) Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors: a phase II randomized study. Neuro Oncol 16:584–588

pubmed: 24311644 doi: 10.1093/neuonc/not170

Maschio M, Pauletto G, Zarabla A et al (2019) Perampanel in patients with brain tumor-related epilepsy in real-life clinical practice: a retrospective analysis. Int J Neurosci 129:593–597

pubmed: 30507318 doi: 10.1080/00207454.2018.1555160

Bedetti C, Romoli M, Maschio M et al (2017) Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study. Eur J Neurol 24:1283–1289

pubmed: 28796376 doi: 10.1111/ene.13375

Acharya S, Bussel JB (2000) Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol 22:62–65

pubmed: 10695824 doi: 10.1097/00043426-200001000-00012

Ruda R, Pellerino A, Franchino F et al (2018) Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study. J Neurooncol 136:105–114

pubmed: 29030718 doi: 10.1007/s11060-017-2628-0

Glantz MJ, Cole BF, Forsyth PA et al (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886–1893

pubmed: 10822423 doi: 10.1212/WNL.54.10.1886

Mamon HJ, Wen PY, Burns AC et al (1999) Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy. Epilepsia 40:341–344

pubmed: 10080516 doi: 10.1111/j.1528-1157.1999.tb00715.x

Mikkelsen T, Paleologos NA, Robinson PD et al (2010) The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:97–102

pubmed: 19957015 doi: 10.1007/s11060-009-0056-5

Milligan TA, Hurwitz S, Bromfield EB (2008) Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery. Neurology 71:665–669

pubmed: 18725591 doi: 10.1212/01.wnl.0000324624.52935.46

Lwu S, Hamilton MG, Forsyth PA et al (2010) Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience. J Neurooncol 96:403–408

pubmed: 19669097 doi: 10.1007/s11060-009-9977-2

Sughrue ME, Rutkowski MJ, Chang EF et al (2011) Postoperative seizures following the resection of convexity meningiomas: are prophylactic anticonvulsants indicated? Clinical article. J Neurosurg 114:705–709

pubmed: 20578801 doi: 10.3171/2010.5.JNS091972

Kuijlen JM, Teernstra OP, Kessels AG et al (1996) Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis. Seizure 5:291–298

pubmed: 8952015 doi: 10.1016/S1059-1311(96)80023-9

Zachenhofer I, Donat M, Oberndorfer S et al (2011) Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery. J Neurooncol 101:101–106

pubmed: 20526797 doi: 10.1007/s11060-010-0235-4

Komotar RJ, Raper DM, Starke RM et al (2011) Prophylactic antiepileptic drug therapy in patients undergoing supratentorial meningioma resection: a systematic analysis of efficacy. J Neurosurg 115:483–490

pubmed: 21639698 doi: 10.3171/2011.4.JNS101585

Wu AS, Trinh VT, Suki D et al (2013) A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J Neurosurg 118:873–883

pubmed: 23394340 pmcid: 4083773 doi: 10.3171/2012.12.JNS111970

Fuller KL, Wang YY, Cook MJ et al (2013) Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study. Epilepsia 54:45–57

pubmed: 22738092 doi: 10.1111/j.1528-1167.2012.03563.x

Chandra V, Rock AK, Opalak C et al (2017) A systematic review of perioperative seizure prophylaxis during brain tumor resection: the case for a multicenter randomized clinical trial. Neurosurg Focus 43:E18

pubmed: 29088958 doi: 10.3171/2017.8.FOCUS17442

Greenhalgh J, Weston J, Dundar Y et al (2020) Antiepileptic drugs as prophylaxis for postcraniotomy seizures. Cochrane Database System Rev 4:CD007286

Riedl J, Ay C (2019) Venous thromboembolism in brain tumors: risk factors, molecular mechanisms, and clinical challenges. Semin Thromb Hemost 45:334–341

pubmed: 31041803 pmcid: 6548560 doi: 10.1055/s-0039-1688493

Brat DJ, Van Meir EG (2004) Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Investig 84:397–405

pubmed: 14990981 doi: 10.1038/labinvest.3700070

Muster V, Gary T (2020) Incidence, therapy, and bleeding risk-cancer- associated thrombosis in patients with glioblastoma. Cancers (Basel) 12:1354

pubmed: 32466430 doi: 10.3390/cancers12061354

Lyman GH, Bohlke K, Khorana AA et al (2015) Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. J Clin Oncol 33:654–656

pubmed: 25605844 pmcid: 4881372 doi: 10.1200/JCO.2014.59.7351

Jo JT, Schiff D, Perry JR (2014) Thrombosis in brain tumors. Semin Thromb Hemost 40:325–331

pubmed: 24599439 doi: 10.1055/s-0034-1370791

Le Rhun E, Genbrugge E, Stupp R et al (2018) Associations of anticoagulant use with outcome in newly diagnosed glioblastoma. Eur J Cancer 101:95–104

pubmed: 30036741 doi: 10.1016/j.ejca.2018.06.029

Khorana AA, Otten HM, Zwicker JI et al (2014) Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH. J Thromb Haemost 12:1928–1931

pubmed: 25208230 doi: 10.1111/jth.12725

Faraoni D, Comes RF, Geerts W et al (2018) European guidelines on perioperative venous thromboembolism prophylaxis: Neurosurgery. Eur J Anaesthesiol 35:90–95

pubmed: 29112542 doi: 10.1097/EJA.0000000000000710

Key NS, Khorana AA, Kuderer NM et al (2020) Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 38:496–520

pubmed: 31381464 doi: 10.1200/JCO.19.01461

Revilla-Pacheco F, Rodriguez-Salgado P, Barrera-Ramirez M et al (2021) Extent of resection and survival in patients with glioblastoma multiforme: systematic review and meta-analysis. Medicine 100:e26432

pubmed: 34160432 pmcid: 8238332 doi: 10.1097/MD.0000000000026432

Sanai N, Berger MS (2018) Surgical oncology for gliomas: the state of the art. Nat Rev Clin Oncol 15:112–125

pubmed: 29158591 doi: 10.1038/nrclinonc.2017.171

Altieri R, Barbagallo D, Certo F et al (2021) Peritumoral microenvironment in high-grade gliomas: from FLAIRectomy to microglia-glioma cross-talk. Brain sciences 11:200

pubmed: 33561993 pmcid: 7915863 doi: 10.3390/brainsci11020200

Almeida JP, Chaichana KL, Rincon-Torroella J et al (2015) The value of extent of resection of glioblastomas: clinical evidence and current approach. Curr Neurol Neurosci Rep 15:517

pubmed: 25467408 doi: 10.1007/s11910-014-0517-x

Molinaro AM, Hervey-Jumper S, Morshed RA et al (2020) Association of maximal extent of resection of contrast-enhanced and non-contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma. JAMA Oncol 6:495–503

pubmed: 32027343 pmcid: 7042822 doi: 10.1001/jamaoncol.2019.6143

Oppenlander ME, Wolf AB, Snyder LA et al (2014) An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity. J Neurosurg 120:846–853

pubmed: 24484232 doi: 10.3171/2013.12.JNS13184

Roder C, Bisdas S, Ebner FH et al (2014) Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery. Eur J Surg 40:297–304

doi: 10.1016/j.ejso.2013.11.022

Sanai N, Polley MY, McDermott MW et al (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3–8

pubmed: 21417701 doi: 10.3171/2011.2.JNS10998

Sezer S, van Amerongen MJ, Delye HHK et al (2020) Accuracy of the neurosurgeons estimation of extent of resection in glioblastoma. Acta Neurochir 162:373–378

pubmed: 31656985 doi: 10.1007/s00701-019-04089-8

Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972

pubmed: 20231676 doi: 10.1200/JCO.2009.26.3541

McGirt MJ, Chaichana KL, Gathinji M et al (2009) Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 110:156–162

pubmed: 18847342 doi: 10.3171/2008.4.17536

Li YM, Suki D, Hess K et al (2016) The influence of maximum safe resection of glioblastoma on survival in 1229 patients: can we do better than gross-total resection? J Neurosurg 124:977–988

pubmed: 26495941 doi: 10.3171/2015.5.JNS142087

Stummer W, Pichlmeier U, Meinel T et al (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392–401

pubmed: 16648043 doi: 10.1016/S1470-2045(06)70665-9

Grabowski MM, Recinos PF, Nowacki AS et al (2014) Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. J Neurosurg 121:1115–1123

pubmed: 25192475 doi: 10.3171/2014.7.JNS132449

Pessina F, Navarria P, Cozzi L et al (2017) Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience. J Neurooncol 135:129–139

pubmed: 28689368 doi: 10.1007/s11060-017-2559-9

Schupper AJ, Yong RL, Hadjipanayis CG (2021) The neurosurgeon’s armamentarium for gliomas: an update on intraoperative technologies to improve extent of resection. J Clin Med 10:236

pubmed: 33440712 pmcid: 7826675 doi: 10.3390/jcm10020236

Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

pubmed: 15758009 doi: 10.1056/NEJMoa043330

Keles GE, Lamborn KR, Chang SM et al (2004) Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy. J Neurosurg 100:41–46

pubmed: 14743910 doi: 10.3171/jns.2004.100.1.0041

Sanai N, Berger MS (2011) Extent of resection influences outcomes for patients with gliomas. Revue Neurologique 167:648–654

pubmed: 21903234 doi: 10.1016/j.neurol.2011.07.004

Certo F, Altieri R, Maione M et al (2021) FLAIRectomy in supramarginal resection of glioblastoma correlates with clinical outcome and survival analysis: a prospective, single institution, case series. Operat Neurosurg 20:151–163

doi: 10.1093/ons/opaa293

Altieri R, Melcarne A, Soffietti R et al (2019) Supratotal resection of glioblastoma: is less more? Surg Technol Int 35:432–440

pubmed: 31373379

Mampre D, Ehresman J, Pinilla-Monsalve G et al (2018) Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes. Br J Neurosurg 32:528–535

pubmed: 30073866 doi: 10.1080/02688697.2018.1498450

Karschnia P, Young JS, Dono A et al (2022) Prognostic validation of a new classification system for extent of resection in glioblastoma: a report of the RANO resect group. J Neuro Oncol. https://doi.org/10.1200/JCO.2022.40.16_suppl.2003

doi: 10.1200/JCO.2022.40.16_suppl.2003

Mazzucchi E, La Rocca G, Ius T et al (2020) Multimodality imaging techniques to assist surgery in low-grade gliomas. World Neurosurg 133:423–425

pubmed: 31881559 doi: 10.1016/j.wneu.2019.10.120

Barbagallo G, Maione M, Peschillo S et al (2019) Intraoperative computed tomography, navigated ultrasound, 5-amino-levulinic acid fluorescence and neuromonitoring in brain tumor surgery: overtreatment or useful tool combination? J Neurosurg Sci. https://doi.org/10.23736/S0390-5616.19.04735-0

doi: 10.23736/S0390-5616.19.04735-0 pubmed: 31355623

Roland JL, Hacker CD, Leuthardt EC (2020) A review of passive brain mapping techniques in neurological surgery. Neurosurgery 88:15–24

pubmed: 33231261 doi: 10.1093/neuros/nyaa361

Spena G, Nava A, Cassini F et al (2010) Preoperative and intraoperative brain mapping for the resection of eloquent-area tumors: a prospective analysis of methodology, correlation, and usefulness based on clinical outcomes. Acta Neurochir 152:1835–1846

pubmed: 20730457 doi: 10.1007/s00701-010-0764-9

Raffa G, Conti A, Scibilia A et al (2017) Functional reconstruction of motor and language pathways based on navigated transcranial magnetic stimulation and DTI fiber tracking for the preoperative planning of low grade glioma surgery: a new tool for preservation and restoration of eloquent networks. Acta Neurochir Suppl 124:251–261

pubmed: 28120081 doi: 10.1007/978-3-319-39546-3_37

Steinmeier R, Sobottka SB, Reiss G et al (2002) Surgery of low-grade gliomas near speech-eloquent regions: brainmapping versus preoperative functional imaging. Onkologie 25:552–557

pubmed: 12566901

Manan HA, Franz EA, Yahya N (2020) Utilization of functional MRI language paradigms for pre-operative mapping: a systematic review. Neuroradiology 62:353–367

pubmed: 31802156 doi: 10.1007/s00234-019-02322-w

Castellano A, Cirillo S, Bello L et al (2017) Functional MRI for surgery of gliomas. Curr Treat Options Neurol 19:34

pubmed: 28831723 doi: 10.1007/s11940-017-0469-y

Bizzi A, Blasi V, Falini A et al (2008) Presurgical functional MR imaging of language and motor functions: validation with intraoperative electrocortical mapping. Radiology 248:579–589

pubmed: 18539893 doi: 10.1148/radiol.2482071214

Zaca D, Corsini F, Rozzanigo U et al (2018) Whole-brain network connectivity underlying the human speech articulation as emerged integrating direct electric stimulation, resting state fmri and tractography. Front Hum Neurosci 12:405

pubmed: 30364298 pmcid: 6193478 doi: 10.3389/fnhum.2018.00405

Zaca D, Jovicich J, Corsini F et al (2018) ReStNeuMap: a tool for automatic extraction of resting-state functional MRI networks in neurosurgical practice. J Neurosurg 131:764–771

pubmed: 30485221 doi: 10.3171/2018.4.JNS18474

Silva MA, See AP, Essayed WI et al (2018) Challenges and techniques for presurgical brain mapping with functional MRI. NeuroImage Clin 17:794–803

pubmed: 29270359 doi: 10.1016/j.nicl.2017.12.008

Black DF, Vachha B, Mian A et al (2017) American society of functional neuroradiology-recommended fMRI paradigm algorithms for presurgical language assessment. AJNR Am J Neuroradiol 38:E65–E73

pubmed: 28860215 pmcid: 7963630 doi: 10.3174/ajnr.A5345

DeYoe EA, Raut RV (2014) Visual mapping using blood oxygen level dependent functional magnetic resonance imaging. Neuroimaging Clin N Am 24:573–584

pubmed: 25441501 pmcid: 4255289 doi: 10.1016/j.nic.2014.08.001

Pujol J, Deus J, Acebes JJ et al (2008) Identification of the sensorimotor cortex with functional MRI: frequency and actual contribution in a neurosurgical context. J Neuroimaging 18:28–33

pubmed: 18190492 doi: 10.1111/j.1552-6569.2007.00175.x

Bizzi A (2009) Presurgical mapping of verbal language in brain tumors with functional MR imaging and MR tractography. Neuroimaging Clin N Am 19:573–596

pubmed: 19959006 doi: 10.1016/j.nic.2009.08.010

Kuchcinski G, Mellerio C, Pallud J et al (2015) Three-tesla functional MR language mapping: comparison with direct cortical stimulation in gliomas. Neurology 84:560–568

pubmed: 25589667 doi: 10.1212/WNL.0000000000001226

Giussani C, Roux FE, Ojemann J et al (2010) Is preoperative functional magnetic resonance imaging reliable for language areas mapping in brain tumor surgery? Review of language functional magnetic resonance imaging and direct cortical stimulation correlation studies. Neurosurgery 66:113–120

pubmed: 19935438 doi: 10.1227/01.NEU.0000360392.15450.C9

Lefaucheur JP, Picht T (2016) The value of preoperative functional cortical mapping using navigated TMS. Neurophysiologie Clinique/Clin Neurophysiol 46:125–133

doi: 10.1016/j.neucli.2016.05.001

Rizzo V, Terranova C, Conti A et al (2014) Preoperative functional mapping for rolandic brain tumor surgery. Neurosci Lett 583:136–141

pubmed: 25224631 doi: 10.1016/j.neulet.2014.09.017

Raffa G, Quattropani MC, Germano A (2019) When imaging meets neurophysiology: the value of navigated transcranial magnetic stimulation for preoperative neurophysiological mapping prior to brain tumor surgery. Neurosurg Focus 47:E10

pubmed: 31786549 doi: 10.3171/2019.9.FOCUS19640

Rossini PM, Barker AT, Berardelli A et al (1994) Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 91:79–92

pubmed: 7519144 doi: 10.1016/0013-4694(94)90029-9

Krieg SM, Lioumis P, Makela JP et al (2017) Protocol for motor and language mapping by navigated TMS in patients and healthy volunteers; workshop report. Acta Neurochir 159:1187–1195

pubmed: 28456870 doi: 10.1007/s00701-017-3187-z

Lioumis P, Zhdanov A, Makela N et al (2012) A novel approach for documenting naming errors induced by navigated transcranial magnetic stimulation. J Neurosci Methods 204:349–354

pubmed: 22108143 doi: 10.1016/j.jneumeth.2011.11.003

Giglhuber K, Maurer S, Zimmer C et al (2017) Evoking visual neglect-like deficits in healthy volunteers—an investigation by repetitive navigated transcranial magnetic stimulation. Brain Imaging Behav 11:17–29

pubmed: 26781482 doi: 10.1007/s11682-016-9506-9

Giglhuber K, Maurer S, Zimmer C et al (2018) Mapping visuospatial attention: the greyscales task in combination with repetitive navigated transcranial magnetic stimulation. BMC Neurosci 19:40

pubmed: 29996777 pmcid: 6042394 doi: 10.1186/s12868-018-0440-1

Hannula H, Neuvonen T, Savolainen P et al (2010) Increasing top-down suppression from prefrontal cortex facilitates tactile working memory. Neuroimage 49:1091–1098

pubmed: 19643184 doi: 10.1016/j.neuroimage.2009.07.049

Maurer S, Tanigawa N, Sollmann N et al (2016) Non-invasive mapping of calculation function by repetitive navigated transcranial magnetic stimulation. Brain Struct Funct 221:3927–3947

pubmed: 26507738 doi: 10.1007/s00429-015-1136-2

Picht T, Krieg SM, Sollmann N et al (2013) A comparison of language mapping by preoperative navigated transcranial magnetic stimulation and direct cortical stimulation during awake surgery. Neurosurgery 72:808–819

pubmed: 23385773 doi: 10.1227/NEU.0b013e3182889e01

Picht T, Schmidt S, Brandt S et al (2011) Preoperative functional mapping for rolandic brain tumor surgery: comparison of navigated transcranial magnetic stimulation to direct cortical stimulation. Neurosurgery 69:581–588

pubmed: 21430587 doi: 10.1227/NEU.0b013e3182181b89

Zdunczyk A, Fleischmann R, Schulz J et al (2013) The reliability of topographic measurements from navigated transcranial magnetic stimulation in healthy volunteers and tumor patients. Acta Neurochir 155:1309–1317

pubmed: 23479092 doi: 10.1007/s00701-013-1665-5

Krieg SM, Sollmann N, Tanigawa N et al (2016) Cortical distribution of speech and language errors investigated by visual object naming and navigated transcranial magnetic stimulation. Brain Struct Funct 221:2259–2286

pubmed: 25894631 doi: 10.1007/s00429-015-1042-7

Mangraviti A, Casali C, Cordella R et al (2013) Practical assessment of preoperative functional mapping techniques: navigated transcranial magnetic stimulation and functional magnetic resonance imaging. Neurol Sci 34:1551–1557

pubmed: 23266868 doi: 10.1007/s10072-012-1283-7

Coburger J, Musahl C, Henkes H et al (2013) Comparison of navigated transcranial magnetic stimulation and functional magnetic resonance imaging for preoperative mapping in rolandic tumor surgery. Neurosurg Rev 36:65–75

pubmed: 22886323 doi: 10.1007/s10143-012-0413-2

Forster MT, Hattingen E, Senft C et al (2011) Navigated transcranial magnetic stimulation and functional magnetic resonance imaging: advanced adjuncts in preoperative planning for central region tumors. Neurosurgery 68:1317–1324

pubmed: 21273929 doi: 10.1227/NEU.0b013e31820b528c

Frey D, Schilt S, Strack V et al (2014) Navigated transcranial magnetic stimulation improves the treatment outcome in patients with brain tumors in motor eloquent locations. Neuro Oncol 16:1365–1372

pubmed: 24923875 pmcid: 4165423 doi: 10.1093/neuonc/nou110

Krieg SM, Sabih J, Bulubasova L et al (2014) Preoperative motor mapping by navigated transcranial magnetic brain stimulation improves outcome for motor eloquent lesions. Neuro Oncol 16:1274–1282

pubmed: 24516237 pmcid: 4136889 doi: 10.1093/neuonc/nou007

Picht T, Frey D, Thieme S et al (2016) Presurgical navigated TMS motor cortex mapping improves outcome in glioblastoma surgery: a controlled observational study. J Neurooncol 126:535–543

pubmed: 26566653 doi: 10.1007/s11060-015-1993-9

Raffa G, Scibilia A, Conti A et al (2019) The role of navigated transcranial magnetic stimulation for surgery of motor-eloquent brain tumors: a systematic review and meta-analysis. Clin Neurol Neurosurg 180:7–17

pubmed: 30870762 doi: 10.1016/j.clineuro.2019.03.003

Raffa G, Picht T, Angileri FF et al (2019) Surgery of malignant motor-eloquent gliomas guided by sodium-fluorescein and navigated transcranial magnetic stimulation: a novel technique to increase the maximal safe resection. J Neurosurg Sci 63:670–678

pubmed: 31079439

Raffa G, Scibilia A, Conti A et al (2019) Multimodal surgical treatment of high-grade gliomas in the motor area: the impact of the combination of navigated transcranial magnetic stimulation and fluorescein-guided resection. World Neurosurg 128:e378–e390

pubmed: 31029822 doi: 10.1016/j.wneu.2019.04.158

Ille S, Sollmann N, Butenschoen VM et al (2016) Resection of highly language-eloquent brain lesions based purely on rTMS language mapping without awake surgery. Acta Neurochir 158:2265–2275

pubmed: 27688208 doi: 10.1007/s00701-016-2968-0

Raffa G, Quattropani MC, Scibilia A et al (2018) Surgery of language-eloquent tumors in patients not eligible for awake surgery: the impact of a protocol based on navigated transcranial magnetic stimulation on presurgical planning and language outcome, with evidence of tumor-induced intra-hemispheric plasticity. Clin Neurol Neurosurg 168:127–139

pubmed: 29549813 doi: 10.1016/j.clineuro.2018.03.009

Sollmann N, Ille S, Hauck T et al (2015) The impact of preoperative language mapping by repetitive navigated transcranial magnetic stimulation on the clinical course of brain tumor patients. BMC Cancer 15:261

pubmed: 25885761 pmcid: 4404089 doi: 10.1186/s12885-015-1299-5

Catani M, Howard RJ, Pajevic S et al (2002) Virtual in vivo interactive dissection of white matter fasciculi in the human brain. Neuroimage 17:77–94

pubmed: 12482069 doi: 10.1006/nimg.2002.1136

ffytche DH, Catani M (2005) Beyond localization: from hodology to function. Phil Trans R Soc Lond B Biol Sci 360:767–779

doi: 10.1098/rstb.2005.1621

Vanderweyen DC, Theaud G, Sidhu J et al (2020) The role of diffusion tractography in refining glial tumor resection. Brain Struct Funct 225:1413–1436

pubmed: 32180019 doi: 10.1007/s00429-020-02056-z

Conti A, Raffa G, Granata F et al (2014) Navigated transcranial magnetic stimulation for “somatotopic” tractography of the corticospinal tract. Neurosurgery 10(Suppl 4):542–554

pubmed: 25072115

Duffau H (2014) The dangers of magnetic resonance imaging diffusion tensor tractography in brain surgery. World Neurosurg 81:56–58

pubmed: 23376386 doi: 10.1016/j.wneu.2013.01.116

Rheault F, De Benedictis A, Daducci A et al (2020) Tractostorm: The what, why, and how of tractography dissection reproducibility. Hum Brain Mapp 41:1859–1874

pubmed: 31925871 pmcid: 7267902 doi: 10.1002/hbm.24917

Berto G, Bullock D, Astolfi P et al (2021) Classifyber, a robust streamline-based linear classifier for white matter bundle segmentation. Neuroimage 224:117402

pubmed: 32979520 doi: 10.1016/j.neuroimage.2020.117402

Farquharson S, Tournier JD, Calamante F et al (2013) White matter fiber tractography: why we need to move beyond DTI. J Neurosurg 118:1367–1377

pubmed: 23540269 doi: 10.3171/2013.2.JNS121294

Zhan L, Leow AD, Jahanshad N et al (2010) How does angular resolution affect diffusion imaging measures? Neuroimage 49:1357–1371

pubmed: 19819339 doi: 10.1016/j.neuroimage.2009.09.057

Schult T, Hauser TK, Klose U et al (2019) Fiber visualization for preoperative glioma assessment: tractography versus local connectivity mapping. PLoS ONE 14:e0226153

pubmed: 31830068 pmcid: 6907809 doi: 10.1371/journal.pone.0226153

Ashmore J, Pemberton HG, Crum WD et al (2020) Implementation of clinical tractography for pre-surgical planning of space occupying lesions: an investigation of common acquisition and post-processing methods compared to dissection studies. PLoS ONE 15:e0231440

pubmed: 32287298 pmcid: 7156092 doi: 10.1371/journal.pone.0231440

Mormina E, Longo M, Arrigo A et al (2015) MRI tractography of corticospinal tract and arcuate fasciculus in high-grade gliomas performed by constrained spherical deconvolution: qualitative and quantitative analysis. AJNR Am J Neuroradiol 36:1853–1858

pubmed: 26113071 pmcid: 7965052 doi: 10.3174/ajnr.A4368

Bucci M, Mandelli ML, Berman JI et al (2013) Quantifying diffusion MRI tractography of the corticospinal tract in brain tumors with deterministic and probabilistic methods. NeuroImage Clinical 3:361–368

pubmed: 24273719 pmcid: 3815019 doi: 10.1016/j.nicl.2013.08.008

Caverzasi E, Hervey-Jumper SL, Jordan KM et al (2016) Identifying preoperative language tracts and predicting postoperative functional recovery using HARDI q-ball fiber tractography in patients with gliomas. J Neurosurg 125:33–45

pubmed: 26654181 doi: 10.3171/2015.6.JNS142203

Frey D, Strack V, Wiener E et al (2012) A new approach for corticospinal tract reconstruction based on navigated transcranial stimulation and standardized fractional anisotropy values. Neuroimage 62:1600–1609

pubmed: 22659445 doi: 10.1016/j.neuroimage.2012.05.059

Krieg SM, Buchmann NH, Gempt J et al (2012) Diffusion tensor imaging fiber tracking using navigated brain stimulation–a feasibility study. Acta Neurochir 154:555–563

pubmed: 22270529 doi: 10.1007/s00701-011-1255-3

Negwer C, Sollmann N, Ille S et al (2017) Language pathway tracking: comparing nTMS-based DTI fiber tracking with a cubic ROIs-based protocol. J Neurosurg 126:1006–1014

pubmed: 27231977 doi: 10.3171/2016.2.JNS152382

Raffa G, Bahrend I, Schneider H et al (2016) A novel technique for region and linguistic specific nTMS-based DTI fiber tracking of language pathways in brain tumor patients. Front Neurosci 10:552

pubmed: 27994536 pmcid: 5134322 doi: 10.3389/fnins.2016.00552

Sollmann N, Negwer C, Ille S et al (2016) Feasibility of nTMS-based DTI fiber tracking of language pathways in neurosurgical patients using a fractional anisotropy threshold. J Neurosci Methods 267:45–54

pubmed: 27059128 doi: 10.1016/j.jneumeth.2016.04.002

Ottenhausen M, Krieg SM, Meyer B et al (2015) Functional preoperative and intraoperative mapping and monitoring: increasing safety and efficacy in glioma surgery. Neurosurg Focus 38:E3

pubmed: 25552283 doi: 10.3171/2014.10.FOCUS14611

Raffa G, Conti A, Scibilia A et al (2018) The impact of diffusion tensor imaging fiber tracking of the corticospinal tract based on navigated transcranial magnetic stimulation on surgery of motor-eloquent brain lesions. Neurosurgery 83:768–782

pubmed: 29211865 doi: 10.1093/neuros/nyx554

Sollmann N, Giglhuber K, Tussis L et al (2015) nTMS-based DTI fiber tracking for language pathways correlates with language function and aphasia—a case report. Clin Neurol Neurosurg 136:25–28

pubmed: 26056808 doi: 10.1016/j.clineuro.2015.05.023

Sanvito F, Caverzasi E, Riva M et al (2020) fMRI-targeted high-angular resolution diffusion MR tractography to identify functional language tracts in healthy controls and glioma patients. Front Neurosci 14:225

pubmed: 32296301 pmcid: 7136614 doi: 10.3389/fnins.2020.00225

Campanella M, Ius T, Skrap M et al (2014) Alterations in fiber pathways reveal brain tumor typology: a diffusion tractography study. PeerJ 2:e497

pubmed: 25250209 pmcid: 4168762 doi: 10.7717/peerj.497

Cargnelutti E, Ius T, Skrap M et al (2020) What do we know about pre- and postoperative plasticity in patients with glioma? A review of neuroimaging and intraoperative mapping studies. NeuroImage Clin 28:102435

pubmed: 32980599 pmcid: 7522801 doi: 10.1016/j.nicl.2020.102435

Jenkinson MD, Barone DG, Bryant A et al (2018) Intraoperative imaging technology to maximise extent of resection for glioma. Cochrane Database System Rev 1:CD012788

Altieri R, Melcarne A, Di Perna G et al (2018) Intra-operative ultrasound: tips and tricks for making the most in neurosurgery. Surg Technol Int 33:353–360

pubmed: 30117132

Coburger J, Hagel V, Wirtz CR et al (2015) Surgery for glioblastoma: impact of the combined use of 5-aminolevulinic acid and intraoperative mri on extent of resection and survival. PLoS ONE 10:e0131872

pubmed: 26115409 pmcid: 4482740 doi: 10.1371/journal.pone.0131872

Della Pepa GM, Ius T, La Rocca G et al (2020) 5-aminolevulinic acid and contrast-enhanced ultrasound: the combination of the two techniques to optimize the extent of resection in glioblastoma surgery. Neurosurgery 86:E529–E540

pubmed: 32186345 doi: 10.1093/neuros/nyaa037

Faust K, Schneider GH, Vajkoczy P (2019) Utilization of the intraoperative mobile AIRO(R) CT scanner in stereotactic surgery: workflow and effectiveness. Stereotact Funct Neurosurg 97:303–312

pubmed: 31962324 doi: 10.1159/000504945

Mahboob S, McPhillips R, Qiu Z et al (2016) Intraoperative ultrasound-guided resection of gliomas: a meta-analysis and review of the literature. World Neurosurg 92:255–263

pubmed: 27178235 doi: 10.1016/j.wneu.2016.05.007

Orillac C, Stummer W, Orringer DA (2020) Fluorescence guidance and intraoperative adjuvants to maximize extent of resection. Neurosurgery 89:727–736

pmcid: 8510852 doi: 10.1093/neuros/nyaa475

Ganslandt O, Behari S, Gralla J et al (2002) Neuronavigation: concept, techniques and applications. Neurol India 50:244–255

pubmed: 12391447

Wang MN, Song ZJ (2011) Classification and analysis of the errors in neuronavigation. Neurosurgery 68:1131–1143

pubmed: 21242841 doi: 10.1227/NEU.0b013e318209cc45

Shalit MN, Israeli Y, Matz S et al (1979) Intra-operative computerized axial tomography. Surg Neurol 11:382–384

pubmed: 441930

Yamashita S, Fujisawa M, Kodama K et al (2013) Use of preoperative 3D CT/MR fusion images and intraoperative CT to detect lesions that spread onto the brain surface. Acta Neurochir Suppl 118:239–244

pubmed: 23564140 doi: 10.1007/978-3-7091-1434-6_45

Hosoda T, Takeuchi H, Hashimoto N et al (2011) Usefulness of intraoperative computed tomography in surgery for low-grade gliomas: a comparative study between two series without and with intraoperative computed tomography. Neurol Med Chir 51:490–495

doi: 10.2176/nmc.51.490

Prada F, Del Bene M, Mattei L et al (2015) Preoperative magnetic resonance and intraoperative ultrasound fusion imaging for real-time neuronavigation in brain tumor surgery. Ultraschall Med 36:174–186

pubmed: 25429625

Pavlov V, Meyronet D, Meyer-Bisch V et al (2016) Intraoperative probe-based confocal laser endomicroscopy in surgery and stereotactic biopsy of low-grade and high-grade gliomas: a feasibility study in humans. Neurosurgery 79:604–612

pubmed: 27643918 doi: 10.1227/NEU.0000000000001365

La Rocca G, Sabatino G, Menna G et al (2020) 5-aminolevulinic acid false positives in cerebral neuro-oncology: not all that is fluorescent is tumor. a case-based update and literature review. World Neurosurg 137:187–193

pubmed: 32058110 doi: 10.1016/j.wneu.2020.01.238

Picart T, Armoiry X, Berthiller J et al (2017) Is fluorescence-guided surgery with 5-ala in eloquent areas for malignant gliomas a reasonable and useful technique? Neurochirurgie 63:189–196

pubmed: 28522184 doi: 10.1016/j.neuchi.2016.12.005

Manini I, Caponnetto F, Dalla E et al (2020) Heterogeneity matters: different regions of glioblastoma are characterized by distinctive tumor-supporting pathways. Cancers (Basel) 12:2960

pubmed: 33066172 doi: 10.3390/cancers12102960

Acerbi F, Broggi M, Broggi G et al (2015) What is the best timing for fluorescein injection during surgical removal of high-grade gliomas? Acta Neurochir 157:1377–1378

pubmed: 26021579 doi: 10.1007/s00701-015-2455-z

Schebesch KM, Proescholdt M, Hohne J et al (2013) Sodium fluorescein-guided resection under the YELLOW 560 nm surgical microscope filter in malignant brain tumor surgery–a feasibility study. Acta Neurochir 155:693–699

pubmed: 23430234 doi: 10.1007/s00701-013-1643-y

Palmieri G, Cofano F, Salvati LF et al (2021) Fluorescence-guided surgery for high-grade gliomas: state of the art and new perspectives. Technol Cancer Res Treat 20:15330338211021604

pubmed: 34212784 pmcid: 8255554 doi: 10.1177/15330338211021605

Young JS, Gogos AJ, Aabedi AA et al (2021) Resection of supplementary motor area gliomas: revisiting supplementary motor syndrome and the role of the frontal aslant tract. J Neurosurg 23:1–7

Berger MS (1995) Functional mapping-guided resection of low-grade gliomas. Clin Neurosurg 42:437–452

pubmed: 8846609

Ius T, Mazzucchi E, Tomasino B et al (2021) Multimodal integrated approaches in low grade glioma surgery. Sci Rep 11:9964

pubmed: 33976246 pmcid: 8113473 doi: 10.1038/s41598-021-87924-2

Sanai N, Mirzadeh Z, Berger MS (2008) Functional outcome after language mapping for glioma resection. N Engl J Med 358:18–27

pubmed: 18172171 doi: 10.1056/NEJMoa067819

Bello L, Riva M, Fava E et al (2014) Tailoring neurophysiological strategies with clinical context enhances resection and safety and expands indications in gliomas involving motor pathways. Neuro Oncol 16:1110–1128

pubmed: 24500420 pmcid: 4096171 doi: 10.1093/neuonc/not327

Sala F (2018) Penfield’s stimulation for direct cortical motor mapping: an outdated technique? Clin Neurophysiol 129:2635–2637

pubmed: 30424944 doi: 10.1016/j.clinph.2018.09.021

Taniguchi M, Cedzich C, Schramm J (1993) Modification of cortical stimulation for motor evoked potentials under general anesthesia: technical description. Neurosurgery 32:219–226

pubmed: 8437660 doi: 10.1227/00006123-199302000-00011

Schucht P, Seidel K, Beck J et al (2014) Intraoperative monopolar mapping during 5-ALA-guided resections of glioblastomas adjacent to motor eloquent areas: evaluation of resection rates and neurological outcome. Neurosurg Focus 37:E16

pubmed: 25434385 doi: 10.3171/2014.10.FOCUS14524

Raabe A, Beck J, Schucht P et al (2014) Continuous dynamic mapping of the corticospinal tract during surgery of motor eloquent brain tumors: evaluation of a new method. J Neurosurg 120:1015–1024

pubmed: 24628613 doi: 10.3171/2014.1.JNS13909

Gogos AJ, Young JS, Morshed RA et al (2020) Triple motor mapping: transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways. J Neurosurg 134:1728–1737

pubmed: 32502996 doi: 10.3171/2020.3.JNS193434

Lombardi G, Barresi V, Castellano A et al (2020) Clinical management of diffuse low-grade gliomas. Cancers (Basel) 12:3008

pubmed: 33081358 doi: 10.3390/cancers12103008

Ruda R, Angileri FF, Ius T et al (2020) Italian consensus and recommendations on diagnosis and treatment of low-grade gliomas: an intersociety (SINch/AINO/SIN) document. J Neurosurg Sci 64:313–334

pubmed: 32347684 doi: 10.23736/S0390-5616.20.04982-6

Kotrotsou A, Elakkad A, Sun J et al (2018) Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome. J Neurooncol 139:125–133

pubmed: 29619649 doi: 10.1007/s11060-018-2850-4

Zelitzki R, Korn A, Arial E et al (2019) Comparison of motor outcome in patients undergoing awake vs general anesthesia surgery for brain tumors located within or adjacent to the motor pathways. Neurosurgery 85:E470–E476

pubmed: 30783667 doi: 10.1093/neuros/nyz007

Brem H, Piantadosi S, Burger PC et al (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Polym-brain Tumor Treatment Group Lancet 345:1008–1012

pubmed: 7723496

Westphal M, Hilt DC, Bortey E et al (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5:79–88

pubmed: 12672279 pmcid: 1920672 doi: 10.1093/neuonc/5.2.79

Schueller P, Micke O, Palkovic S et al (2005) 12 years’ experience with intraoperative radiotherapy (IORT) of malignant gliomas. Strahlentherapie und Onkologie 181:500–506

pubmed: 16044217 doi: 10.1007/s00066-005-1354-2

Usychkin S, Calvo F, dos Santos MA et al (2013) Intra-operative electron beam radiotherapy for newly diagnosed and recurrent malignant gliomas: feasibility and long-term outcomes. Clin Transl Oncol 15:33–38

pubmed: 22855176 doi: 10.1007/s12094-012-0892-1

Sarria GR, Sperk E, Han X et al (2020) Intraoperative radiotherapy for glioblastoma: an international pooled analysis. Radiotherapy Oncol 142:162–167

doi: 10.1016/j.radonc.2019.09.023

Kondziolka D, Lunsford LD (1999) The role of stereotactic biopsy in the management of glioma. J Neuro-Oncol 42:205–213

doi: 10.1023/A:1006105415194

Kim JE, Kim DG, Paek SH et al (2003) Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment. Acta Neurochir (Wien) 145:547–554

pubmed: 12910397 doi: 10.1007/s00701-003-0048-8

Dammers R, Haitsma IK, Schouten JW et al (2008) Safety and efficacy of frameless and frame-based intracranial biopsy techniques. Acta Neurochir (Wien) 150:23–29

pubmed: 18172567 doi: 10.1007/s00701-007-1473-x

Lu Y, Yeung C, Radmanesh A et al (2015) Comparative effectiveness of frame-based, frameless, and intraoperative magnetic resonance imaging-guided brain biopsy techniques. World Neurosurg 83:261–268

pubmed: 25088233 doi: 10.1016/j.wneu.2014.07.043

Watanabe E, Watanabe T, Manaka S et al (1987) Three-dimensional digitizer (neuronavigator): new equipment for computed tomography-guided stereotaxic surgery. Surg Neurol 27:543–547

pubmed: 3554569 doi: 10.1016/0090-3019(87)90152-2

Wu S, Wang J, Gao P et al (2020) A comparison of the efficacy, safety, and duration of frame-based and Remebot robot-assisted frameless stereotactic biopsy. Br J Neurosurg 35:1–5

Bruno F, Pellerino A, Pronello E et al (2022) Elderly gliobastoma patients: the impact of surgery and adjuvant treatments on survival: a single institution experience. Brain Sci 12:632

pubmed: 35625018 pmcid: 9139732 doi: 10.3390/brainsci12050632

Moriarty TM, Quinones-Hinojosa A, Larson PS et al (2000) Frameless stereotactic neurosurgery using intraoperative magnetic resonance imaging: stereotactic brain biopsy. Neurosurgery 47:1138–1145

pubmed: 11063107 doi: 10.1097/00006123-200011000-00023

Lefranc M, Monet P, Desenclos C et al (2012) Perfusion MRI as a neurosurgical tool for improved targeting in stereotactic tumor biopsies. Stereotact Funct Neurosurg 90:240–247

pubmed: 22699810 doi: 10.1159/000338092

McKnight TR, von dem Bussche MH, Vigneron DB et al (2002) Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97:794–802

pubmed: 12405365 doi: 10.3171/jns.2002.97.4.0794

Grech-Sollars M, Vaqas B, Thompson G et al (2017) An MRS- and PET-guided biopsy tool for intraoperative neuronavigational systems. J Neurosurg 127:812–818

pubmed: 27834593 doi: 10.3171/2016.7.JNS16106

Pirotte B, Goldman S, Massager N et al (2004) Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies. J Neurosurg 101:476–483

pubmed: 15352606 doi: 10.3171/jns.2004.101.3.0476

Chen CC, Hsu PW, Erich Wu TW et al (2009) Stereotactic brain biopsy: Single center retrospective analysis of complications. Clin Neurol Neurosurg 111:835–839

pubmed: 19765887 doi: 10.1016/j.clineuro.2009.08.013

Hall WA (1998) The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 82:1749–1755

pubmed: 9576298 doi: 10.1002/(SICI)1097-0142(19980501)82:9<1756::AID-CNCR23>3.0.CO;2-2

Ferreira MP, Ferreira NP, Pereira Filho Ade A et al (2006) Stereotactic computed tomography-guided brain biopsy: diagnostic yield based on a series of 170 patients. Surg Neurol 65(S1):27-1–32

McGirt MJ, Woodworth GF, Coon AL et al (2005) Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg 102:897–901

pubmed: 15926716 doi: 10.3171/jns.2005.102.5.0897

Kulkarni AV, Guha A, Lozano A et al (1998) Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg 89:31–35

pubmed: 9647169 doi: 10.3171/jns.1998.89.1.0031

Grossman R, Sadetzki S, Spiegelmann R et al (2005) Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies. Acta Neurochir (Wien) 147:627–631

pubmed: 15821863 doi: 10.1007/s00701-005-0495-5

Malone H, Yang J, Hershman DL et al (2015) Complications following stereotactic needle biopsy of intracranial tumors. World Neurosurg 84:1084–1089

pubmed: 26008141 doi: 10.1016/j.wneu.2015.05.025

Steinmetz MP, Barnett GH, Kim BS et al (2001) Metastatic seeding of the stereotactic biopsy tract in glioblastoma multiforme: case report and review of the literature. J Neurooncol 55:167–171

pubmed: 11859971 doi: 10.1023/A:1013873431159

Perrin RG, Bernstein M (1998) Iatrogenic seeding of anaplastic astrocytoma following stereotactic biopsy. J Neurooncol 36:243–246

pubmed: 9524102 doi: 10.1023/A:1005823805767

Patel N, Sandeman D (1997) A simple trajectory guidance device that assists freehand and interactive image guided biopsy of small deep intracranial targets. Comput Aid Surg 2:186–192

doi: 10.3109/10929089709148112

Paleologos TS, Dorward NL, Wadley JP et al (2001) Clinical validation of true frameless stereotactic biopsy: analysis of the first 125 consecutive cases. Neurosurgery 49:830–835

pubmed: 11564243

Chang JH, Kim CY, Choi BS et al (2014) Pseudoprogression and pseudoresponse in the management of high-grade glioma : optimal decision timing according to the response assessment of the neuro-oncology working group. J Korean Neurosurg Soc 55:5–11

pubmed: 24570811 pmcid: 3928350 doi: 10.3340/jkns.2014.55.1.5

Parvez K, Parvez A, Zadeh G (2014) The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence. Int J Mol Sci 15:11832–11846

pubmed: 24995696 pmcid: 4139817 doi: 10.3390/ijms150711832

Sughrue ME, Sheean T, Bonney PA et al (2015) Aggressive repeat surgery for focally recurrent primary glioblastoma: outcomes and theoretical framework. Neurosurg Focus 38:E11

pubmed: 25727220 doi: 10.3171/2014.12.FOCUS14726

Sastry RA, Shankar GM, Gerstner ER et al (2018) The impact of surgery on survival after progression of glioblastoma: a retrospective cohort analysis of a contemporary patient population. J Clin Neurosci 53:41–47

pubmed: 29680441 doi: 10.1016/j.jocn.2018.04.004

Kamp MA, Felsberg J, Sadat H et al (2015) 5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy. Acta Neurochirurgica 157:207–213

pubmed: 25547719 doi: 10.1007/s00701-014-2313-4

Li X, Jia Z, Yan Y (2022) Efficacy and safety of tumor-treating fields in recurrent glioblastoma: a systematic review and meta-analysis. Acta Neurochir 164:1985–1993

pubmed: 35397674 doi: 10.1007/s00701-022-05192-z

Filippini G, Falcone C, Boiardi A et al (2008) Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol 10:79–87

pubmed: 17993634 pmcid: 2600841 doi: 10.1215/15228517-2007-038

De Bonis P, Fiorentino A, Anile C et al (2013) The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma. Clin Neurol Neurosurg 115:883–886

pubmed: 22959214 doi: 10.1016/j.clineuro.2012.08.030

Hickmann AK, Nadji-Ohl M, Hopf NJ (2015) Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients. J Neurooncol 122:151–160

pubmed: 25557106 doi: 10.1007/s11060-014-1694-9

Barbagallo GMV, Certo F, Di Gregorio S et al (2021) Recurrent high-grade glioma surgery: a multimodal intraoperative protocol to safely increase extent of tumor resection and analysis of its impact on patient outcome. Neurosurg Focus 50:E20

pubmed: 33386001 doi: 10.3171/2020.10.FOCUS20744

Vargas Lopez AJ, Fernandez Carballal C, Valera Mele M et al (2020) Survival analysis in high-grade glioma: the role of salvage surgery. Neurologia 38:21–28

Lombardi G, De Salvo GL, Brandes AA et al (2019) Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet Oncol 20:110–119

pubmed: 30522967 doi: 10.1016/S1470-2045(18)30675-2

Chang SM, Prados MD, Yung WK et al (2004) Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial. Cancer 100:1712–1716

pubmed: 15073861 doi: 10.1002/cncr.20157

Cloughesy TF, Mochizuki AY, Orpilla JR et al (2019) Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med 25:477–486

pubmed: 30742122 pmcid: 6408961 doi: 10.1038/s41591-018-0337-7

Stupp R, Hegi ME, van den Bent MJ et al (2006) Changing paradigms–an update on the multidisciplinary management of malignant glioma. Oncologist 11:165–180

pubmed: 16476837 doi: 10.1634/theoncologist.11-2-165

Clark AJ, Lamborn KR, Butowski NA et al (2012) Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment. Neurosurgery 70:361–370

pubmed: 21841523 doi: 10.1227/NEU.0b013e3182314f9d

Clark AJ, Butowski NA, Chang SM et al (2011) Impact of bevacizumab chemotherapy on craniotomy wound healing. J Neurosurg 114:1609–1616

pubmed: 21142749 doi: 10.3171/2010.10.JNS101042

Pinsker M, Lumenta C (2001) Experiences with reoperation on recurrent glioblastoma multiforme. Zentralbl Neurochir 62:43–47

pubmed: 11786935

Ortega A, Sarmiento JM, Ly D et al (2016) Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era. J Clin Neurosci 24:105–111

pubmed: 26671314 doi: 10.1016/j.jocn.2015.05.047

Woernle CM, Peus D, Hofer S et al (2015) Efficacy of surgery and further treatment of progressive glioblastoma. World Neurosurg 84:301–307

pubmed: 25797075 doi: 10.1016/j.wneu.2015.03.018

Zanello M, Roux A, Ursu R et al (2017) Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment? J Neurooncol 135:285–297

pubmed: 28726173 doi: 10.1007/s11060-017-2573-y

Nobusawa S, Watanabe T, Kleihues P et al (2009) IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res 15:6002–6007

pubmed: 19755387 doi: 10.1158/1078-0432.CCR-09-0715

Ohgaki H, Dessen P, Jourde B et al (2004) Genetic pathways to glioblastoma: a population-based study. Can Res 64:6892–6899

doi: 10.1158/0008-5472.CAN-04-1337

Ohgaki H, Kleihues P (2013) The definition of primary and secondary glioblastoma. Clin Cancer Res 19:764–772

pubmed: 23209033 doi: 10.1158/1078-0432.CCR-12-3002

Schucht P, Murek M, Jilch A et al (2013) Early re-do surgery for glioblastoma is a feasible and safe strategy to achieve complete resection of enhancing tumor. PLoS ONE 8:e79846

pubmed: 24348904 pmcid: 3865346 doi: 10.1371/journal.pone.0079846

Minniti G, Lombardi G, Paolini S (2019) Glioblastoma in elderly patients: current management and future perspectives. Cancers 11:336

pubmed: 30857221 pmcid: 6469025 doi: 10.3390/cancers11030336

Buckner JC (2003) Factors influencing survival in high-grade gliomas. Semin Oncol 30:10–14

pubmed: 14765378 doi: 10.1053/j.seminoncol.2003.11.031

Barbagallo GMV, Altieri R, Garozzo M et al (2020) High grade glioma treatment in elderly people: is it different than in younger patients? Analysis of surgical management guided by an intraoperative multimodal approach and its impact on clinical outcome. Front Oncol 10:631255

pubmed: 33718122 doi: 10.3389/fonc.2020.631255

Kita D, Ciernik IF, Vaccarella S et al (2009) Age as a predictive factor in glioblastomas: population-based study. Neuroepidemiology 33:17–22

pubmed: 19325245 doi: 10.1159/000210017

Paszat L, Laperriere N, Groome P et al (2001) A population-based study of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 51:100–107

pubmed: 11516858 doi: 10.1016/S0360-3016(01)01572-3

Barnholtz-Sloan JS, Williams VL, Maldonado JL et al (2008) Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg 108:642–648

pubmed: 18377240 doi: 10.3171/JNS/2008/108/4/0642

Amsbaugh MJ, Yusuf MB, Gaskins J et al (2017) Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma an analysis of the national cancer data base. Cancer 123:3277–3284

pubmed: 28452053 doi: 10.1002/cncr.30730

Ius T, Somma T, Altieri R et al (2020) Is age an additional factor in the treatment of elderly patients with glioblastoma? A new stratification model: an Italian Multicenter Study. Neurosurg Focus 49:E13

pubmed: 33002864 doi: 10.3171/2020.7.FOCUS20420

Han Q, Liang H, Cheng P et al (2020) Gross total vs subtotal resection on survival outcomes in elderly patients with high-grade glioma: a systematic review and meta-analysis. Front Oncol 10:151

pubmed: 32257941 pmcid: 7093492 doi: 10.3389/fonc.2020.00151

Okada M, Miyake K, Tamiya T (2017) Glioblastoma treatment in the elderly. Neurol Med Chir 57:667–676

doi: 10.2176/nmc.ra.2017-0009

Navarria P, Pessina F, Franzese C et al (2021) The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing. Radiotherapy Oncol 156:49–55

doi: 10.1016/j.radonc.2020.11.022

Laigle-Donadey F (2021) PL03.1.A surgery for glioblastomas in the elderly: an ANOCEF trial (CSA). Neuro-Oncology. https://doi.org/10.1093/neuonc/noab180.003

doi: 10.1093/neuonc/noab180.003 pubmed: 33825892 pmcid: 8563312

Wick W, Platten M, Meisner C et al (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13:707–715

pubmed: 22578793 doi: 10.1016/S1470-2045(12)70164-X

Almenawer SA, Badhiwala JH, Alhazzani W et al (2015) Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis. Neuro Oncol 17:868–881

pubmed: 25556920 pmcid: 4483123 doi: 10.1093/neuonc/nou349

Babu R, Komisarow JM, Agarwal VJ et al (2016) Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival. J Neurosurg 124:998–1007

pubmed: 26452121 doi: 10.3171/2015.4.JNS142200

Chaichana KL, Chaichana KK, Olivi A et al (2011) Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival: clinical article. J Neurosurg 114:587–594

pubmed: 20887095 doi: 10.3171/2010.8.JNS1081

Noorbakhsh A, Tang JA, Marcus LP et al (2014) Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis. J Neurosurg 120:31–39

pubmed: 24205904 doi: 10.3171/2013.9.JNS13877

Vuorinen V, Hinkka S, Farkkila M et al (2003) Debulking or biopsy of malignant glioma in elderly people—a randomised study. Acta Neurochir 145:5–10

pubmed: 12545256 doi: 10.1007/s00701-002-1030-6

Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch®): a systematic review.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Pagination

Informations de copyright

Références

Auteurs

Articles similaires

Classifications MeSH